SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
-40.93%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$94.6M
AUM Growth
-$48.9M
(-34%)
Cap. Flow
+$20M
Cap. Flow
% of AUM
21.15%
Top 10 Holdings %
Top 10 Hldgs %
59.92%
Holding
33
New
10
Increased
9
Reduced
7
Closed
7
Top Buys
| 1 |
Ligand Pharmaceuticals
LGND
|
$11.7M |
| 2 |
STML
Stemline Therapeutics, Inc.
STML
|
$4.29M |
| 3 |
Cidara Therapeutics
CDTX
|
$3.23M |
| 4 |
Gyre Therapeutics
GYRE
|
$3.11M |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$2.86M |
Top Sells
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$3.12M |
| 2 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$2.76M |
| 3 |
Aptevo Therapeutics
APVO
|
$2.74M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$2.37M |
| 5 |
AFMD
Affimed
AFMD
|
$1.6M |
Sector Composition
| 1 | Healthcare | 91.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rigel Pharmaceuticals
RIGL
$742M
| $16K | 0.02% |
+1,000
| New | +$16K |
|
27
Adicet Bio
ACET
$60M
| – | – |
-11,682
| Closed | -$122K |
|
|
28
Aptevo Therapeutics
APVO
$5.29M
| – | – |
-9
| Closed | -$2.74M |
|
29
SCYNEXIS
SCYX
$37.3M
| – | – |
-60,938
| Closed | -$555K |
|
|
ACER
30
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| – | – |
-20,000
| Closed | -$80K |
|
|
SBBP
31
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – |
-431,853
| Closed | -$903K |
|
|
NVLN
32
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| – | – |
-3,909,207
| Closed | -$2.76M |
|